1. Drugless nanoparticles tune-up an array of intertwined pathways contributing to immune checkpoint signaling and metabolic reprogramming in triple-negative breast cancer
   Asmaa Ramzy et al, 2023, Biomedical Materials CrossRef
2. Shuyu pills inhibit immune escape and enhance chemosensitization in hepatocellular carcinoma
   Zhe Deng et al, 2021, World Journal of Gastrointestinal Oncology CrossRef
3. High Concentration of Dezocine Induces Immune Escape of Lung Cancer and Promotes Glucose Metabolism through Up-Regulating PD-L1 and Activating the NF-κB Pathway
   Weiping Dong et al, 2022, Current Molecular Medicine CrossRef
4. Development and Validation of a Combined Glycolysis and Immune Prognostic Model for Melanoma
   Yang Yang et al, 2021, Frontiers in Immunology CrossRef
5. T-Cell Metabolism and Its Regulation by Checkpoint Molecules: Consequences for Cancer Immunotherapy
   Susana Romero-Garcia et al, 2023, Handbook of Cancer and Immunology CrossRef
6. Research Progress of Long Non-Coding RNA Regulating Glucose Metabolism in Acute My-eloid Leukemia Cells
   汉 王, 2022, Advances in Clinical Medicine CrossRef
7. Glycolysis-related biomarker TCIRG1 participates in regulation of renal cell carcinoma progression and tumor immune microenvironment by affecting aerobic glycolysis and AKT/mTOR signaling pathway
   Sichen Di et al, 2023, Cancer Cell International CrossRef
8. LRRC1 knockdown downregulates MACF1 to inhibit the malignant progression of acute myeloid leukemia by inactivating β-catenin/c-Myc signaling
   Yao Wang et al, 2024, Journal of Molecular Histology CrossRef
9. Targeting Thyrointegrin αvβ3 Using Fluorobenzyl Polyethylene Glycol Conjugated Tetraiodothyroacetic Acid (NP751) in Acute Myeloid Leukemia
   Noureldien H. E. Darwish et al, 2022, Frontiers in Oncology CrossRef
10. Partners in crime: The feedback loop between metabolic reprogramming and immune checkpoints in the tumor microenvironment
    Jesus J. Benito-Lopez et al, 2023, Frontiers in Oncology CrossRef